Riskpilot← Back to searchSign inGet full accessINPROTHER ApS
APSActiveCVR 33968426Nordre Fasanvej 215Research and experimental development on natural sciences and engineering · NACE 7210Est. 201119 employeeswww.hervolutiontx.com
Revenue 2024
DKK -2,6M
+734% vs 2023
EBITDA margin
357.9%
-32% vs 2023
Equity ratio
65.0%
Financial strength
Net profit 2024
DKK -8,6M
-16% vs 2023
| Revenue | DKK -2,6M | +734% |
| EBITDA | DKK -9,3M | -32% |
| Net profit | DKK -8,6M | -16% |
| Total assets | DKK 116,8M | +205% |
| Equity | DKK 75,9M | +372% |
| Employees | 19 | — |
Legal name
INPROTHER ApS
CVR number
33968426
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24. oktober 2011
Share capital
DKK 229.156
Employees
19 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør.
Company purpose
Selskabets formål er at udvikle immunterapier mod kræft, aldring og neurodegenerative sygdomme som ALS, MS og Alzheimers samt enhver anden virksomhed, som bestyrelsen anser for at være forbundet hermed.
Address
Nordre Fasanvej 215
Email
contact@hervolutiontx.com
Website
www.hervolutiontx.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -170 | -60 | 33 | -24 | 10 | 126 | 158 | -2.002 | -2.744 | -1.780 | -2.138 | -310 | -2.587 |
| Staff expenses | -61 | -76 | -17 | -0 | -0 | -110 | -220 | -5.084 | -5.799 | -3.427 | -10.287 | -6.708 | -6.671 |
| EBITDA | -232 | -136 | 17 | -25 | 10 | 16 | -62 | -7.086 | -8.543 | -5.207 | -12.424 | -7.018 | -9.258 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1.924 |
| EBIT | -232 | -136 | 17 | -25 | 10 | 16 | -62 | -7.086 | -8.543 | -5.207 | -12.424 | -7.018 | -11.182 |
| Net financials | -1 | -0 | 0 | 0 | 0 | -0 | -3 | -262 | -665 | -667 | -1.922 | -2.587 | -878 |
| Profit before tax | -232 | -136 | 17 | -25 | 10 | 15 | -65 | -7.349 | -9.208 | -5.874 | -14.346 | -9.604 | -12.060 |
| Tax | -58 | -32 | 5 | 16 | -0 | -0 | -0 | -1.617 | -2.232 | -2.135 | -2.759 | -2.159 | -3.438 |
| Net profit | -174 | -104 | 11 | -40 | 10 | 15 | -65 | -5.732 | -6.976 | -3.739 | -11.587 | -7.446 | -8.622 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 366 | 226 | 131 | 82 | 271 | 227 | 296 | 3.967 | 10.320 | 20.630 | 24.465 | 38.276 | 116.780 |
| Equity | 206 | 101 | 113 | 72 | 82 | 97 | 32 | -5.681 | -2.063 | -5.801 | -20.422 | -27.868 | 75.881 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.260 | 10.784 | 23.901 | 41.891 | 31.486 | 33.103 |
| Short-term debt | 160 | 125 | 18 | 10 | 189 | 129 | 264 | 1.387 | 1.598 | 2.530 | 2.995 | 34.657 | 7.797 |
| Total debt | 160 | 125 | 18 | 10 | 189 | 129 | 264 | 9.648 | 12.383 | 26.432 | 44.886 | 66.143 | 40.900 |
EBITDA margin
-925771900.0%
This company
15.8%
Market median
-5859315923% vs market
20122024
Equity ratio
65.0%
This company
38.2%
Market median
+70% vs market
20122024
Return on equity
-11.4%
This company
18.4%
Market median
-162% vs market
20122024
Net profit margin
-862154300.0%
This company
8.1%
Market median
-10643880347% vs market
20122024
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122024
Debt / equity
0.54×
This company
0.62×
Market median
+13% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2011-10-24 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
NJ Founder | Founder | 2011 | — | — |
JN Chief Executive Officer | Chief Executive Officer | 2021 | — | — |
MK Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
KA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PETER HOLST CONSULTING ApS | Company | 33.3% | 33.3% | 2019 |
| Individual | 20.0% | 20.0% | 2024 | |
| Individual | 15.0% | 15.0% | 2024 | |
BIOSTRAT BIOTECH CONSULTING ApS | Company | 5.0% | 5.0% | 2020 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of INPROTHER ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nikolaj Juhl Hansen | Founder | 0 companies |
| Jordi Naval Chamosa | Chief Executive Officer | 0 companies |
| Mathias Kroll | Chief Executive Officer | 0 companies |
| Kim Arvid Nielsen | Chief Executive Officer | 0 companies |
| Christian Olivier Thirion | Board of Directors | 0 companies |
| Peter Johannes Holst | Board of Directors | 0 companies |
| Jesper Zeuthen | Chairman | 0 companies |
| Michael Sven Rohmann | Board of Directors | 0 companies |
| Peter Samuel Wulff | Board of Directors | 0 companies |
| John Robert M Coleman | Chairman | 0 companies |
| Nicolaj Højer Nielsen | Board of Directors | 0 companies |